These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 10507079)
1. Markers of function and proliferation in non-invasive and invasive bi- and plurihormonal adenomas of patients with acromegaly: an immunohistochemical study. Müller W; Saeger W; Wellhausen L; Derwahl KM; Hamacher C; Lüdecke DK Pathol Res Pract; 1999; 195(9):595-603. PubMed ID: 10507079 [TBL] [Abstract][Full Text] [Related]
2. A clinicomorphological study of pituitary tumors associated with the clinical syndrome of acromegaly. Andreeva M; Georgiev T; Bosadjieva E; Karagiosov L; Karagiosov K; Tomova A; Matrosov P; Kirilov G; Diankov L; Christova T Exp Clin Endocrinol; 1991; 98(3):223-7. PubMed ID: 1778242 [TBL] [Abstract][Full Text] [Related]
3. Alpha-subunit immunoreactivity in plurihormonal pituitary adenomas of patients with acromegaly. Kontogeorgos G; Kovacs K; Scheithauer BW; Rologis D; Orphanidis G Mod Pathol; 1991 Mar; 4(2):191-5. PubMed ID: 1646455 [TBL] [Abstract][Full Text] [Related]
5. [Immunohistochemistry for pituitary hormones and Ki-67 in growth hormone producing pituitary adenomas]. Brito J; Sáez L; Lemp M; Liberman C; Michelsen H; Araya AV Rev Med Chil; 2008 Jul; 136(7):831-6. PubMed ID: 18949157 [TBL] [Abstract][Full Text] [Related]
6. Hormone secretion in vitro by plurihormonal pituitary adenomas of the acidophil cell line. Asa SL; Kovacs K; Horvath E; Singer W; Smyth HS J Clin Endocrinol Metab; 1992 Jul; 75(1):68-75. PubMed ID: 1352308 [TBL] [Abstract][Full Text] [Related]
7. Expression of Ki-67, p53 and vascular endothelial growth factor (VEGF) concomitantly in growth hormone-secreting pituitary adenomas; which one has a role in tumor behavior ? Yarman S; Kurtulmus N; Canbolat A; Bayindir C; Bilgic B; Ince N Neuro Endocrinol Lett; 2010; 31(6):823-8. PubMed ID: 21196926 [TBL] [Abstract][Full Text] [Related]
8. Prolactin presents in all pituitary tumors of acromegalic patients. Furuhata S; Kameya T; Otani M; Toya S Hum Pathol; 1993 Jan; 24(1):10-5. PubMed ID: 8418010 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of GH-producing adenomas--with special emphasis on plurihormonality of individual tumor cells by double staining. Inada K; Oda K; Utsunomiya H; Itoh J; Osamura RY Tokai J Exp Clin Med; 1992 Dec; 17(5-6):213-22. PubMed ID: 1285309 [TBL] [Abstract][Full Text] [Related]
10. Functioning and non-functioning pituitary adenomas in 173 adult and elderly patients. Gasco V; Gaia D; Tassone F; Razzore P; Ciccarelli E; Grottoli S J Endocrinol Invest; 2002; 25(10 Suppl):57-8. PubMed ID: 12508919 [No Abstract] [Full Text] [Related]
11. Immunohistochemical detection of estrogen receptor alpha in pituitary adenomas and its correlation with cellular replication. Pereira-Lima JF; Marroni CP; Pizarro CB; Barbosa-Coutinho LM; Ferreira NP; Oliveira MC Neuroendocrinology; 2004 Mar; 79(3):119-24. PubMed ID: 15103224 [TBL] [Abstract][Full Text] [Related]
13. Folliculo-stellate cells in pituitary adenomas of patients with acromegaly. Voit D; Saeger W; Lüdecke DK Pathol Res Pract; 1999; 195(3):143-7. PubMed ID: 10220793 [TBL] [Abstract][Full Text] [Related]
14. Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly. Arafah BM; Rosenzweig JL; Fenstermaker R; Salazar R; McBride CE; Selman W J Lab Clin Med; 1987 Mar; 109(3):346-54. PubMed ID: 3102658 [TBL] [Abstract][Full Text] [Related]
15. Percent reduction of growth hormone levels correlates closely with percent resected tumor volume in acromegaly. Schwyzer L; Starke RM; Jane JA; Oldfield EH J Neurosurg; 2015 Apr; 122(4):798-802. PubMed ID: 25423276 [TBL] [Abstract][Full Text] [Related]
16. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure? Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870 [TBL] [Abstract][Full Text] [Related]
17. Prognostic relevance of intracytoplasmic cytokeratin pattern, hormone expression profile, and cell proliferation in pituitary adenomas of akromegalic patients. Mazal PR; Czech T; Sedivy R; Aichholzer M; Wanschitz J; Klupp N; Budka H Clin Neuropathol; 2001; 20(4):163-71. PubMed ID: 11495005 [TBL] [Abstract][Full Text] [Related]
18. Electron microscopical morphometry of pituitary adenomas. Comparison of tumours in acromegaly and hyperprolactinemia. Saeger W; Kant P; Caselitz J; Lüdecke DK Pathol Res Pract; 1988 Feb; 183(1):17-24. PubMed ID: 3362748 [TBL] [Abstract][Full Text] [Related]
19. Transsphenoidal adenomectomy for growth hormone-secreting pituitary adenomas in acromegaly: outcome analysis and determinants of failure. Tindall GT; Oyesiku NM; Watts NB; Clark RV; Christy JH; Adams DA J Neurosurg; 1993 Feb; 78(2):205-15. PubMed ID: 8421204 [TBL] [Abstract][Full Text] [Related]
20. Metabolic glucose status and pituitary pathology portend therapeutic outcomes in acromegaly. Cheng S; Al-Agha R; Araujo PB; Serri O; L Asa S; Ezzat S PLoS One; 2013; 8(9):e73543. PubMed ID: 24039977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]